These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33347425)

  • 1. The impact of physical frailty on the response to inactivated influenza vaccine in older adults.
    Moehling KK; Zhai B; Schwarzmann WE; Chandran UR; Ortiz M; Nowalk MP; Nace D; Lin CJ; Susick M; Levine MZ; Alcorn JF; Zimmerman RK
    Aging (Albany NY); 2020 Dec; 12(24):24633-24650. PubMed ID: 33347425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
    Front Immunol; 2018; 9():2465. PubMed ID: 30405641
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age.
    Moehling KK; Nowalk MP; Lin CJ; Bertolet M; Ross TM; Carter CE; Susick M; Saul SG; Kaynar AM; Bromberger JT; Zimmerman RK
    Hum Vaccin Immunother; 2018 Feb; 14(2):361-367. PubMed ID: 29172948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with humoral immune response in older adults who received egg-free influenza vaccine.
    Williams KV; Moehling Geffel K; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Susick M; Zimmerman RK
    Vaccine; 2023 Jan; 41(3):862-869. PubMed ID: 36543682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy.
    Gilbert PB; Fong Y; Juraska M; Carpp LN; Monto AS; Martin ET; Petrie JG
    BMC Infect Dis; 2019 May; 19(1):453. PubMed ID: 31117986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.
    Van Epps P; Tumpey T; Pearce MB; Golding H; Higgins P; Hornick T; Burant C; Wilson BM; Banks R; Gravenstein S; Canaday DH
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28100496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
    Williams KV; Zhai B; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Moehling Geffel K; Jaber Merranko A; Nagg JP; Collins M; Susick M; Clarke KS; Zimmerman RK; Martin JM
    Vaccine; 2022 Jan; 40(5):780-788. PubMed ID: 34952751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults.
    Talbot HK; Coleman LA; Zhu Y; Spencer S; Thompson M; Cheng PY; Sundaram ME; Belongia EA; Griffin MR
    BMC Infect Dis; 2015 Apr; 15():195. PubMed ID: 25903659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood.
    Kurupati R; Kossenkov A; Haut L; Kannan S; Xiang Z; Li Y; Doyle S; Liu Q; Schmader K; Showe L; Ertl H
    Oncotarget; 2016 Sep; 7(39):62898-62911. PubMed ID: 27588486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.
    DiazGranados CA; Dunning AJ; Robertson CA; Talbot HK; Landolfi V; Greenberg DP
    Vaccine; 2015 Aug; 33(36):4565-71. PubMed ID: 26187260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age.
    Ross TM; Lin CJ; Nowalk MP; Huang HH; Spencer SM; Shay DK; Sambhara S; Sundaram ME; Friedrich T; Sauereisen S; Bloom CE; Zimmerman RK
    Hum Vaccin Immunother; 2014; 10(5):1195-203. PubMed ID: 24614078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.
    Christian LM; Beverly C; Mitchell AM; Karlsson E; Porter K; Schultz-Cherry S; Ramilo O
    Vaccine; 2017 Sep; 35(39):5283-5290. PubMed ID: 28778612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.
    Lau YF; Tang LH; Chien Lye D; Ooi EE; Leo YS
    Hum Vaccin Immunother; 2017 Mar; 13(3):551-560. PubMed ID: 28277090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring antibody responses to a live attenuated influenza vaccine in children.
    Lee MS; Mahmood K; Adhikary L; August MJ; Cordova J; Cho I; Kemble G; Reisinger K; Walker RE; Mendelman PM
    Pediatr Infect Dis J; 2004 Sep; 23(9):852-6. PubMed ID: 15361726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults.
    Yao X; Hamilton RG; Weng NP; Xue QL; Bream JH; Li H; Tian J; Yeh SH; Resnick B; Xu X; Walston J; Fried LP; Leng SX
    Vaccine; 2011 Jul; 29(31):5015-21. PubMed ID: 21565245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.
    Mbawuike IN; Atmar RL; Patel SM; Corry DB; Winokur PL; Brady RC; Chen WH; Edwards KM; Creech CB; Walter EB; Frey SE; Belshe RB; Goll JB; Hill H; Keitel WA
    Vaccine; 2016 Jan; 34(4):547-554. PubMed ID: 26657997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant.
    Miller PDE; de Silva TI; Leonard H; Anthias C; Hoschler K; Goddard K; Peggs K; Madrigal A; Snowden JA
    Vaccine; 2019 Jan; 37(3):452-457. PubMed ID: 30554797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults.
    Stevanovic G; Lavadinovic L; Filipovic Vignjevic S; Holt R; Ilic K; Berlanda Scorza F; Sparrow E; Stoiljkovic V; Torelli G; Madenwald T; Socquet M; Barac A; Ilieva-Borisova Y; Pelemis M; Flores J
    Hum Vaccin Immunother; 2018 Mar; 14(3):579-586. PubMed ID: 29239682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
    Liu Z; Pang C; Deng Y; Guo C; Li J; Li Y; Xin R; Li X; Xu C; Huang C; Lu H; Li J
    Vaccine; 2023 Jul; 41(34):4978-4985. PubMed ID: 37394372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.